Carlos Quezada Ruiz, MD

Dr. Carlos Quezada-Ruiz, is a clinician and visionary leader with over a decade of clinical experience in vitreoretinal diseases and Drug Development leading large global, cross-functional teams to deliver on high-profile projects and initiatives. Currently, a practicing Retina Specialist and fellow of the American Society of Retina Specialists. He continues to be involved in teaching of residents, fellows, and patient care. His contributions include driving groundbreaking advancements in Retina, including the initiation, execution, and readouts of Global Clinical Trials from Phase 1-3, and securing US and Global Health Authority approvals for Vabysmo in nAMD, and Susvimo.